Veranex Acquires Devicia And Clarvin, Expanding Regulatory, Quality, And Clinical Expertise For Ivd And Medical Devices
Acquiring Company
Veranex
Acquired Company
Devicia
Description
Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired an ecosystem of full-service medical device consultancy companies, providing regulatory and clinical affairs, quality assurance, and biocompatibility services for medical devices and in vitro diagnostic (IVD) devices. Based in Sweden, this ecosystem includes Devicia, a full-service partner offering clinical expertise; Clarvin, a provider of strategic guidance in regulatory affairs and quality assurance; and affiliate companies Kickfile, Lea Reg, and Limulus Bio. Together with the recent acquisition of Swiss-based Medidee, these companies further expand Veranex’s European reach and build regulatory, clinical, and quality service segments. This specifically strengthens Veranex’s medical device regulation (MDR) and in vitro diagnostic regulation (IVDR) strategy, adding expertise in biological evaluations and medical device software and expanding infrastructure and designating local representation in the European Union and United Kingdom.
Quick answer
Veranex is acquiring Devicia and Clarvin, announced October 11, 2022. Veranex is based in Raleigh, North Carolina, United States.
- How much did Veranex pay for Devicia?
- The deal value was not disclosed.
- What does Veranex do?
- Veranex is the world's first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies.
- Where are Veranex and Devicia based?
- Veranex is based in Raleigh, North Carolina, United States.
- Who are the decision-makers at Veranex?
- Fundz holds 3 contacts at Veranex. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Collagen Matrix Acquires Polyganics (October 5, 2022)
- Solesis Acquires Polyzen, Expanding Film And Coating Capabilities (November 2, 2022)
- Sightpath Medical Acquires Accusite Surgical (November 21, 2022)
- Geistlich Pharma North America, Inc. Acquires Lynch Biologics, Llc, A Biologics And Tissue Engineering Company (October 27, 2022)
- Lilly To Acquire Akouos To Discover And Develop Treatments For Hearing Loss (October 18, 2022)
- Azenta Announces Completion Of B Medical Systems Acquisition (October 3, 2022)
Who to call at Veranex, and when
When Veranex changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Veranex raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Veranex, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Veranex. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Veranex makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Devicia?
Devicia was acquired by Veranex, based in Raleigh. The deal was reported on October 11, 2022. Veranex is the world's first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies. Veranex is privately held and operates in Software.
When did Veranex acquire Devicia?
Veranex's acquisition of Devicia was reported on October 11, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Devicia do?
Devicia is a full-service consulting firm offering clinical expertise for medical devices, supporting clients throughout the life cycle of medical device and IVD. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.